Sculati Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.49M Buy
3,564
+43
+1% +$17.1K 0.49% 57
2026
Q2
$1.29M Hold
3,521
– – 0.43% 58
2026
Q1
$1.24M Buy
3,521
+246
+8% +$87.7K 0.46% 61
2025
Q4
$1.07M Buy
3,275
+38
+1% +$12.1K 0.38% 64
2025
Q3
$913K Buy
3,237
+818
+34% +$237K 0.32% 74
2025
Q2
$675K Buy
+2,419
New +$685K 0.25% 78

Other funds holding AMGN

Sculati Wealth Management's AMGN Position: Q3 2026 in Review

Sculati Wealth Management increased its Amgen (AMGN) stake by 1.2% in Q3 2026, buying an estimated $17.1K and bringing the position to 3,564 shares worth $1.49M. The position accounts for 0.49% of the portfolio, ranked #57.

Sculati Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 3,253 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Sculati Wealth Management held 3,564 shares of Amgen worth $1.49M as of Q3 2026.
  • Sculati Wealth Management bought 43 Amgen shares in Q3 2026, an estimated $17.1K.
  • Amgen made up 0.49% of Sculati Wealth Management's portfolio in Q3 2026, its #57 holding.
  • Sculati Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
  • 3,253 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Sculati Wealth Management's 13F filing for Q3 2026, filed 19 Oct 2026.